Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetics of Imatinib in CML Patients in Iran

NCT02146846 is registered in ClinicalTrials.gov with Kerman University of Medical Sciences as lead sponsor.

NCT NCT02146846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02146846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetics of Imatinib in CML Patients in Iran
Lead sponsor
Kerman University of Medical Sciences
Phase
Observational
Overall status
Terminated
Start date
October 31, 2012
Completion date
July 31, 2017
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelogenous leukemia